Testosterone pellet therapy is one of several types of testosterone therapy. Others include nasal sprays, topical gels that are rubbed into the skin daily, and intramuscular injections done every 1 to 2 weeks depending on the doctor’s order. Choosing the type of testosterone therapy to use is a decision that should take several factors into account. Consideration should be given to the physician’s experience and preference, but also your preference.
Testosterone pellets are small, usually 3mm by 9mm long, and contain crystalline testosterone. They are implanted under the skin using an instrument called a trocar, usually near your hip, in a short and simple procedure done by a trained healthcare provider. A local anesthetic is given to reduce any discomfort.
Pellets are a long-acting form of testosterone replacement therapy. They typically deliver a steady dose of testosterone over 4 to 6 months depending on the strength and number of pellets implanted. Pellets may be a good option for those seeking a consistent, long-term dose.
Over several weeks, after implantation, your body will adjust to the new level of testosterone and you should begin to feel the positive effects. Your doctor will help set treatment goals and measure your response by conducting periodic blood tests to measure the level of testosterone in your body.
While pellets provide a stable and steady dose of testosterone, there are considerations for this form of TRT including possible infection at the implantation site, and although very rare, pellet ‘extrusion’ where the pellet works its way out of the skin.
Also, changing the dose is difficult due to the surgical nature of this TRT form. For this reason, some physicians prefer to start their patients on other forms of TRT in order to determine the right dose, before starting their patients on pellet therapy.
Testosterone therapy carries various risks, including contributing to sleep apnea, stimulating noncancerous growth of the prostate, enlarging breasts, limiting sperm production, stimulating growth of existing prostate cancer and blood clots forming in the veins. Men with prostate cancer are not candidates for testosterone replacement therapy.
(87.5mg, 100mg, or 200mg pellet)
Testosterone / Anastrozole Pellet